Divis Laboratories Ltd | DIVI - Operating Profit


Divis Laboratories Ltd reported INR11.29B in Operating Profit for its fiscal quarter ending in June of 2026.





Operating Profit Change Date
Alaunos Therapeutics USD -1.01M 175K Mar/2026
Aurobindo Pharma INR 13.22B 137.6M Mar/2026
Avita Medical AUD -10.41M 742K Dec/2025
Dianthus Therapeutics USD -46.53M 23.01M Mar/2026
Divis Laboratories Ltd INR 11.29B 3.15B Jun/2026
Ionis Pharmaceuticals USD -102.29M 15.71M Jun/2026
IQVIA Holdings USD 2.6B 2.03B Jun/2026
Lupin INR 18.97B 757M Dec/2025
Moderna USD -815M 573M Jun/2026
Organon & Co USD 266M 49M Mar/2026
Revvity USD 126.14M 43.36M Jun/2026
Tectonic Therapeutic USD -27.3M 5.78M Mar/2026
Tilray USD -20.01M 9.34M Sep/2025
Viatris USD -20.2M 137.3M Mar/2026
Xeris Pharmaceuticals USD 7.92M 8.86M Mar/2026